ARCHIVES

Group trials need prioritization, review, NCI official says.

This article is from The Cancer Letter archive.

Vol. 29 No. 30 | July 25, 2003

Download PDF Visit The Full Archive

Related Articles

Nixon Signs Training Grant Bill; No Action Yet On Cancer Act Renewal

July 19, 1974

Sausville to lead clinical research at Maryland.

December 5, 2003

In Brief: Healy To Use 1 Percent Transfer Authority For TB Research; Zoon Heads FDA’s CBER

March 20, 1992

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012

Interview: Von Eschenbach Says His Goal Is to Speed Development of Interventions

March 29, 2002

FDA News: Agency Abandons Plan To Merge Two Offices, Citing Delay Request From Employees’ Union

June 19, 1998